Quick Answer
Outset Medical, Inc. reported Stockholders Equity of $126.95 million for the year ending 2025.
- Outset Medical, Inc. showed an increase of +373.4% in Stockholders Equity from 2024 to 2025.
- This data is from Outset Medical, Inc.'s annual report (Form 10-K), filed with the SEC on February 13, 2026.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2019: -$311.77 million | Q2 2019: -$336.48 million | Q3 2019: -$353.08 million | Q1 2020: -$308.35 million | Q2 2020: -$334.08 million | Q3 2020: $354.33 million | Q1 2021: $306.65 million | Q2 2021: $431.16 million | Q3 2021: $409.75 million | Q1 2022: $345.45 million | Q2 2022: $309.76 million | Q3 2022: $279.10 million | Q1 2023: $216.29 million | Q2 2023: $183.11 million | Q3 2023: $152.06 million | Q1 2024: $93.20 million | Q2 2024: $68.60 million | Q3 2024: $47.82 million | Q1 2025: $169.87 million | Q2 2025: $154.78 million | Q3 2025: $142.37 million.
- Over the full 9 years of available data (2017 to 2025), Outset Medical, Inc.'s Stockholders Equity has grown by 158.8%.
- Historical annual values: Fiscal year 2025: $126.95 million | Fiscal year 2024: $26.82 million | Fiscal year 2023: $122.89 million | Fiscal year 2022: $245.99 million | Fiscal year 2021: $374.08 million | Fiscal year 2020: $328.61 million | Fiscal year 2019: -$372.19 million | Fiscal year 2018: -$287.95 million | Fiscal year 2017: -$215.94 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: